Xylem Stock Issuance Proceeds decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $6.00M to $0.00. Over 4 years (FY 2021 to FY 2025), Stock Issuance Proceeds shows relatively stable performance with a 1.3% CAGR.
Higher proceeds often correlate with employee participation in stock-based compensation programs rather than external capital raising.
Cash inflows resulting from the issuance of common stock, typically through employee stock option exercises or equity co...
Standard for large-cap companies with significant equity-based compensation programs.
proceeds_from_stock_issuance| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.00M | $6.00M | $4.00M | $1.00M | $2.00M | $3.00M | $2.00M | $7.00M | $33.00M | $5.00M | $17.00M | $33.00M | $30.00M | $3.00M | $1.00M | $6.00M | $2.00M | $3.00M | $9.00M | $0.00 |
| QoQ Change | — | +0.0% | -33.3% | -75.0% | +100.0% | +50.0% | -33.3% | +250.0% | +371.4% | -84.8% | +240.0% | +94.1% | -9.1% | -90.0% | -66.7% | +500.0% | -66.7% | +50.0% | +200.0% | -100.0% |
| YoY Change | — | — | — | — | -66.7% | -50.0% | -50.0% | +600.0% | >999% | +66.7% | +750.0% | +371.4% | -9.1% | -40.0% | -94.1% | -81.8% | -93.3% | +0.0% | +800.0% | -100.0% |